Sunday, February 2, 2025

GSK ups 2024 guidance as HIV drugs and new vaccines boost its bottom line

Must read




The British drugmaker’s remaining 4.2% stake in its consumer health arm Haleon also boosted its bottom line, following its spin off in July 2022

Admin (8)

More articles

Latest article